Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer

Microarray studies revealed down-regulation of PCDH9 mRNA level in lymph node metastasis of gastric cancer compared with the primary tumors. The expression of PCDH9 protein and its clinicopathological relevance were assessed on tissue microarrays of 1072 cases of gastric cancer. Its prognostic value was further evaluated on a small cohort of 175 gastric cancers. PCDH9 was down-regulated during the development and progression of gastric cancer. The overall rates of PCDH9 expression in normal, primary tumor, nodal and hepatic metastatic tissues were 100 % (1072/1072), 48.0 % (515/1072), 20.1 % (34/169), and 5.6 % (1/18), respectively. Positive staining of PCDH9 protein was significantly reversely correlated with tumor size, tumor differentiation, tumor invasion, lymph node metastasis, and disease progression. The Cox proportional hazards model revealed that the PCDH9 was an independent prognostic factor for gastric cancer. Therefore, decreased expression of PCDH9 is frequent in human gastric cancer metastasis and PCDH9 expression is an independent prognostic factor, suggesting that PCDH9 could be a promising biomarker of this malignancy.

[1]  Sung-Liang Yu,et al.  Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis , 2014, International journal of cancer.

[2]  S. Leong,et al.  Biomarkers of cancer metastasis through the lymphovascular system: future perspectives , 2012, Clinical & Experimental Metastasis.

[3]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[4]  S. Hirohashi,et al.  Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. , 2006, Cancer research.

[5]  Ying Chen,et al.  Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers , 2014, BMC Cancer.

[6]  S. M,et al.  Cell Adh Migr , 2013 .

[7]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[8]  Chunlin Wang,et al.  Downregulation of PCDH9 predicts prognosis for patients with glioma , 2012, Journal of Clinical Neuroscience.

[9]  Zhe Liu,et al.  Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer , 2011, Molecular and Cellular Biochemistry.

[10]  N. Alfaidy,et al.  Protocadherin-12 Cleavage Is a Regulated Process Mediated by ADAM10 Protein , 2011, The Journal of Biological Chemistry.

[11]  Sangmin Kim,et al.  The Role of the CDH1 Promoter Hypermethylation in the Axillary Lymph Node Metastasis and Prognosis , 2013, Journal of breast cancer.

[12]  Norio Shiraishi,et al.  Lymph Node Metastasis of Gastric Cancer , 2011, Cancers.

[13]  Habtom W Ressom,et al.  Sample type bias in the analysis of cancer genomes. , 2009, Cancer research.

[14]  C. Redies,et al.  δ-Protocadherins: unique structures and functions , 2005, Cellular and Molecular Life Sciences CMLS.

[15]  M. Guan,et al.  High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers. , 2010, Neoplasma.

[16]  D. Hoon,et al.  Epigenetics of regional lymph node metastasis in solid tumors , 2012, Clinical & Experimental Metastasis.

[17]  Qian Tao,et al.  Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. , 2009, Gastroenterology.

[18]  N. Takahashi,et al.  Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. , 2002, Carcinogenesis.

[19]  J. Li,et al.  Down‐regulated SPARCL1 is associated with clinical significance in human gastric cancer , 2012, Journal of surgical oncology.

[20]  Woong Sun,et al.  Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain , 2007, Neuroscience.

[21]  Y. Wang,et al.  Prognosis of colorectal cancer with liver metastasis: value of a prognostic index. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  T. Yılmazlar,et al.  Factors Affecting the Prognosis of Patients with Colorectal Liver Metastasis , 2010, Acta chirurgica Belgica.

[23]  H Glatt,et al.  Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. , 1998, Genomics.

[24]  Q. Ye,et al.  Loss of Heterozygosity at D8S298 Is a Predictor for Long-term Survival of Patients with Tumor-Node-Metastasis Stage I of Hepatocellular Carcinoma , 2007, Clinical Cancer Research.

[25]  Frank Rose,et al.  Metastasis: the seed and soil theory gains identity , 2007, Cancer and Metastasis Reviews.

[26]  H. Liang,et al.  Clinical significance of lymph node metastasis in gastric cancer. , 2014, World journal of gastroenterology.

[27]  Ying Chen,et al.  Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer , 2010, Journal of Cancer Research and Clinical Oncology.

[28]  N. Crawford,et al.  Mechanisms of metastasis , 2008, Breast Cancer Research.

[29]  K. Yamagata,et al.  Non-clustered protocadherin , 2011, Cell adhesion & migration.

[30]  C. Redies,et al.  delta-Protocadherins: unique structures and functions. , 2005, Cellular and molecular life sciences : CMLS.

[31]  L. Hongmei,et al.  Clinical Evaluation of E-cadherin Expression and its Regulation Mechanism in Epithelial Ovarian Cancer , 2006, Clinical & Experimental Metastasis.

[32]  Qiang Li,et al.  Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer , 2008, Clinical & Experimental Metastasis.

[33]  Wei Li,et al.  Protein predictive signatures for lymph node metastasis of gastric cancer , 2013, International journal of cancer.

[34]  Jennifer S. Yu,et al.  PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer , 2008, Oncogene.

[35]  Qiang Li,et al.  Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer , 2009, Clinical Cancer Research.

[36]  Ying Chen,et al.  New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma. , 2008, Oncology reports.